| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | channel activity | CACNA1E PIEZO1 TRPC6 GABRQ PKDREJ LRRC8D RHCE RHD ITPR2 ITPR3 SLC9C1 KCNJ8 KCNJ16 KCNK5 HTR3D GABRA1 GABRA2 | 1.76e-09 | 525 | 104 | 17 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1E PIEZO1 TRPC6 GABRQ PKDREJ LRRC8D RHCE RHD ITPR2 ITPR3 SLC9C1 KCNJ8 KCNJ16 KCNK5 HTR3D GABRA1 GABRA2 | 1.81e-09 | 526 | 104 | 17 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1E PIEZO1 TRPC6 GABRQ PKDREJ LRRC8D ITPR2 ITPR3 SLC9C1 KCNJ8 KCNJ16 KCNK5 HTR3D GABRA1 GABRA2 | 1.55e-08 | 459 | 104 | 15 | GO:0005216 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1E PIEZO1 TRPC6 GABRQ SLC28A3 PKDREJ LRRC8D ITPR2 ITPR3 SLC8A2 SLC9C1 SLC8A3 KCNJ8 KCNJ16 KCNK5 HTR3D GABRA1 GABRA2 | 1.34e-07 | 793 | 104 | 18 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1E TRPC6 GABRQ SLC28A3 PKDREJ RHCE RHD ITPR2 ITPR3 SLC8A2 SLC9C1 SLC8A3 KCNJ8 KCNJ16 KCNK5 GABRA1 GABRA2 | 3.69e-07 | 758 | 104 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1E PIEZO1 GABRQ ITPR2 ITPR3 KCNJ8 KCNJ16 KCNK5 HTR3D GABRA1 GABRA2 | 1.36e-06 | 334 | 104 | 11 | GO:0022836 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1E PIEZO1 TRPC6 GABRQ SLC28A3 PKDREJ LRRC8D RHCE RHD ITPR2 ITPR3 SLC8A2 SLC9C1 SLC8A3 KCNJ8 KCNJ16 KCNK5 HTR3D GABRA1 GABRA2 | 2.52e-06 | 1180 | 104 | 20 | GO:0022857 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1E TRPC6 SLC28A3 PKDREJ RHCE RHD ITPR2 ITPR3 SLC8A2 SLC9C1 SLC8A3 KCNJ8 KCNJ16 KCNK5 | 4.61e-06 | 627 | 104 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | GABA receptor activity | 4.73e-06 | 22 | 104 | 4 | GO:0016917 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1E TRPC6 SLC28A3 PKDREJ ITPR2 ITPR3 SLC8A2 SLC9C1 SLC8A3 KCNJ8 KCNJ16 KCNK5 | 5.49e-06 | 465 | 104 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 7.68e-06 | 193 | 104 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1E PIEZO1 TRPC6 SLC28A3 PKDREJ ITPR2 ITPR3 SLC8A2 SLC9C1 SLC8A3 KCNJ8 KCNJ16 KCNK5 HTR3D | 8.86e-06 | 664 | 104 | 14 | GO:0008324 |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 8.93e-06 | 197 | 104 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1E PIEZO1 TRPC6 GABRQ SLC28A3 PKDREJ LRRC8D RHCE RHD ITPR2 ITPR3 SLC8A2 SLC9C1 SLC8A3 KCNJ8 KCNJ16 KCNK5 HTR3D GABRA1 GABRA2 | 9.48e-06 | 1289 | 104 | 20 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1E PIEZO1 TRPC6 PKDREJ ITPR2 ITPR3 KCNJ8 KCNJ16 KCNK5 HTR3D | 1.23e-05 | 343 | 104 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.42e-05 | 151 | 104 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 4.79e-05 | 14 | 104 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 8.03e-05 | 3 | 104 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 8.03e-05 | 3 | 104 | 2 | GO:1905060 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 1.06e-04 | 18 | 104 | 3 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 1.25e-04 | 19 | 104 | 3 | GO:0004890 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 3.68e-04 | 65 | 104 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 3.68e-04 | 65 | 104 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 3.91e-04 | 66 | 104 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 4.09e-04 | 28 | 104 | 3 | GO:0001972 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.74e-04 | 129 | 104 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 7.02e-04 | 77 | 104 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 7.96e-04 | 35 | 104 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 8.32e-04 | 140 | 104 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | calcium:sodium antiporter activity | 1.18e-03 | 10 | 104 | 2 | GO:0005432 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.24e-03 | 153 | 104 | 5 | GO:0008194 | |
| GeneOntologyMolecularFunction | helicase activity | 1.43e-03 | 158 | 104 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 1.43e-03 | 11 | 104 | 2 | GO:0008503 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 1.46e-03 | 43 | 104 | 3 | GO:0140828 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 1.71e-03 | 12 | 104 | 2 | GO:0008519 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.86e-03 | 100 | 104 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | retinoid binding | 2.00e-03 | 48 | 104 | 3 | GO:0005501 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 2.02e-03 | 13 | 104 | 2 | GO:0015368 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 2.07e-03 | 103 | 104 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 2.12e-03 | 49 | 104 | 3 | GO:0019840 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 2.25e-03 | 50 | 104 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 2.38e-03 | 107 | 104 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 3.27e-03 | 57 | 104 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 3.79e-03 | 60 | 104 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 3.89e-03 | 18 | 104 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.89e-03 | 18 | 104 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 3.98e-03 | 288 | 104 | 6 | GO:0016757 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 4.96e-03 | 211 | 104 | 5 | GO:0016758 | |
| GeneOntologyMolecularFunction | fatty acid binding | 5.61e-03 | 69 | 104 | 3 | GO:0005504 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 6.53e-03 | 645 | 104 | 9 | GO:0140640 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 9.08e-09 | 6 | 104 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 4.21e-07 | 13 | 104 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1E TRPC6 GABRQ SLC28A3 TLR9 PKDREJ RHCE RHD ITPR2 ITPR3 SLC8A2 SLC9C1 SLC8A3 KCNJ8 KCNJ16 KCNK5 HTR3D GABRA1 GABRA2 | 6.94e-07 | 1017 | 104 | 19 | GO:0098660 |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 1.24e-06 | 5 | 104 | 3 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 2.46e-06 | 6 | 104 | 3 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 2.46e-06 | 6 | 104 | 3 | GO:0046226 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 2.50e-06 | 230 | 104 | 9 | GO:0098739 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1E PIEZO1 TRPC6 GABRQ SLC28A3 TLR9 PKDREJ LRRC8D ITPR2 ITPR3 SLC8A2 SLC9C1 SLC8A3 KCNJ8 KCNJ16 KCNK5 HTR3D GABRA1 GABRA2 | 2.72e-06 | 1115 | 104 | 19 | GO:0034220 |
| GeneOntologyBiologicalProcess | hormone catabolic process | 3.42e-06 | 21 | 104 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1E SGK1 PIEZO1 TRPC6 GABRQ SLC28A3 TLR9 PKDREJ LRRC8D ITPR2 ITPR3 SLC8A2 SLC9C1 SLC8A3 KCNJ8 KCNJ16 KCNK5 HTR3D AKT2 GABRA1 GABRA2 | 4.16e-06 | 1374 | 104 | 21 | GO:0006811 |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 7.69e-06 | 142 | 104 | 7 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 7.69e-06 | 142 | 104 | 7 | GO:0098659 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 1.46e-05 | 10 | 104 | 3 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 1.46e-05 | 10 | 104 | 3 | GO:0009804 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1E TRPC6 SLC28A3 TLR9 PKDREJ RHCE RHD ITPR2 ITPR3 SLC8A2 SLC9C1 SLC8A3 KCNJ8 KCNJ16 KCNK5 HTR3D | 1.48e-05 | 922 | 104 | 16 | GO:0098662 |
| GeneOntologyBiologicalProcess | steroid catabolic process | 2.52e-05 | 34 | 104 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 2.83e-05 | 35 | 104 | 4 | GO:0007214 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 3.57e-05 | 180 | 104 | 7 | GO:0060078 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 8.78e-05 | 89 | 104 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 1.01e-04 | 286 | 104 | 8 | GO:0042445 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 1.01e-04 | 147 | 104 | 6 | GO:0099565 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 1.14e-04 | 94 | 104 | 5 | GO:0016101 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | PIEZO1 GABRQ SLC8A2 SLC8A3 KCNJ8 KCNK5 AFDN HTR3D NLGN2 GABRA1 GABRA2 | 1.20e-04 | 559 | 104 | 11 | GO:0042391 |
| GeneOntologyBiologicalProcess | lipid catabolic process | PLB1 NAPEPLD UGT1A10 UGT1A8 UGT1A7 LCT AKT2 ALDH3B2 HSD17B11 | 1.36e-04 | 382 | 104 | 9 | GO:0016042 |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.37e-04 | 52 | 104 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1E SGK1 TRPC6 SLC28A3 TLR9 PKDREJ ITPR2 ITPR3 SLC8A2 SLC9C1 SLC8A3 KCNJ8 KCNJ16 KCNK5 AKT2 | 1.45e-04 | 1000 | 104 | 15 | GO:0030001 |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.55e-04 | 21 | 104 | 3 | GO:0052695 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 1.65e-04 | 392 | 104 | 9 | GO:0070588 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 1.92e-04 | 105 | 104 | 5 | GO:0006721 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1E SGK1 PIEZO1 TRPC6 SLC28A3 TLR9 PKDREJ ITPR2 ITPR3 SLC8A2 SLC9C1 SLC8A3 KCNJ8 KCNJ16 KCNK5 AKT2 | 2.16e-04 | 1157 | 104 | 16 | GO:0006812 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | CACNA1E GABRQ BCHE GABBR2 KMO ITPR3 SLC8A2 SLC8A3 KCNJ8 AFDN HTR3D NLGN2 GABRA1 GABRA2 | 2.39e-04 | 931 | 104 | 14 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | CACNA1E GABRQ BCHE GABBR2 KMO ITPR3 SLC8A2 SLC8A3 KCNJ8 AFDN HTR3D NLGN2 GABRA1 GABRA2 | 2.39e-04 | 931 | 104 | 14 | GO:0007268 |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 2.49e-04 | 5 | 104 | 2 | GO:0052696 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | CACNA1E GABRQ BCHE GABBR2 KMO ITPR3 SLC8A2 SLC8A3 KCNJ8 AFDN HTR3D NLGN2 GABRA1 GABRA2 | 2.61e-04 | 939 | 104 | 14 | GO:0099537 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1E PIEZO1 TRPC6 SLC28A3 TLR9 PKDREJ ITPR2 ITPR3 SLC8A2 SLC9C1 SLC8A3 KCNJ8 KCNJ16 KCNK5 | 2.70e-04 | 942 | 104 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 2.98e-04 | 26 | 104 | 3 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 2.98e-04 | 26 | 104 | 3 | GO:0006063 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 3.26e-04 | 65 | 104 | 4 | GO:0098815 | |
| GeneOntologyBiologicalProcess | ammonium homeostasis | 3.73e-04 | 6 | 104 | 2 | GO:0097272 | |
| GeneOntologyBiologicalProcess | synaptic signaling | CACNA1E GABRQ BCHE GABBR2 KMO ITPR3 SLC8A2 SLC8A3 KCNJ8 AFDN HTR3D NLGN2 GABRA1 GABRA2 | 3.86e-04 | 976 | 104 | 14 | GO:0099536 |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 4.58e-04 | 30 | 104 | 3 | GO:1904862 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 5.14e-04 | 130 | 104 | 5 | GO:0060079 | |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 5.35e-04 | 74 | 104 | 4 | GO:0051932 | |
| GeneOntologyBiologicalProcess | response to iron(II) ion | 6.91e-04 | 8 | 104 | 2 | GO:0010040 | |
| GeneOntologyBiologicalProcess | learning | 7.22e-04 | 212 | 104 | 6 | GO:0007612 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 7.43e-04 | 141 | 104 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 8.17e-04 | 144 | 104 | 5 | GO:0006720 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | SGK1 ACO1 TRPC6 RHCE RHD ITPR2 ITPR3 SLC8A2 SLC9C1 SLC8A3 KCNJ16 | 8.58e-04 | 705 | 104 | 11 | GO:0055080 |
| GeneOntologyBiologicalProcess | glutamate secretion, neurotransmission | 8.86e-04 | 9 | 104 | 2 | GO:0061535 | |
| GeneOntologyBiologicalProcess | peripheral nervous system myelin maintenance | 8.86e-04 | 9 | 104 | 2 | GO:0032287 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 9.17e-04 | 222 | 104 | 6 | GO:0071466 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 9.64e-04 | 605 | 104 | 10 | GO:0071407 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | SGK1 ACO1 TRPC6 RHCE RHD ITPR2 ITPR3 SLC8A2 SLC9C1 SLC8A3 KCNJ16 | 9.84e-04 | 717 | 104 | 11 | GO:0050801 |
| GeneOntologyBiologicalProcess | calcium ion transport | 1.09e-03 | 509 | 104 | 9 | GO:0006816 | |
| GeneOntologyBiologicalProcess | host-mediated regulation of intestinal microbiota composition | 1.10e-03 | 10 | 104 | 2 | GO:0048874 | |
| GeneOntologyBiologicalProcess | marginal zone B cell differentiation | 1.10e-03 | 10 | 104 | 2 | GO:0002315 | |
| GeneOntologyCellularComponent | GABA receptor complex | 3.37e-06 | 21 | 105 | 4 | GO:1902710 | |
| GeneOntologyCellularComponent | postsynaptic membrane | CACNA1E NAPEPLD GABRQ GABBR2 SLC8A2 SLC8A3 AFDN HTR3D NLGN2 GABRA1 GABRA2 | 6.15e-06 | 405 | 105 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1E TRPC6 GABRQ LRRC8D KCNJ8 KCNJ16 KCNK5 HTR3D GABRA1 GABRA2 | 2.08e-05 | 378 | 105 | 10 | GO:0034702 |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1E NAPEPLD GABRQ GABBR2 SLC8A2 SLC8A3 KCNJ8 AFDN HTR3D NLGN2 GABRA1 GABRA2 | 3.64e-05 | 583 | 105 | 12 | GO:0097060 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | NAPEPLD SGK1 UGT1A10 UGT1A8 UGT1A7 CYP17A1 PIEZO1 SLC28A3 BFAR XPO1 TLR9 LRRC8D AWAT2 ITPR2 ITPR3 SLC8A3 STX5 TMED9 | 1.02e-04 | 1327 | 105 | 18 | GO:0042175 |
| GeneOntologyCellularComponent | GABA-A receptor complex | 1.13e-04 | 19 | 105 | 3 | GO:1902711 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | NAPEPLD SGK1 UGT1A10 UGT1A8 UGT1A7 CYP17A1 PIEZO1 SLC28A3 BFAR TLR9 LRRC8D AWAT2 ITPR2 ITPR3 SLC8A3 STX5 TMED9 | 2.36e-04 | 1293 | 105 | 17 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | NAPEPLD SGK1 UGT1A10 UGT1A8 UGT1A7 CYP17A1 PIEZO1 SLC28A3 BFAR TLR9 LRRC8D AWAT2 ITPR2 ITPR3 SLC8A3 STX5 TMED9 | 2.49e-04 | 1299 | 105 | 17 | GO:0098827 |
| GeneOntologyCellularComponent | sarcoplasm | 2.76e-04 | 114 | 105 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1E TRPC6 GABRQ LRRC8D KCNJ8 KCNJ16 KCNK5 HTR3D GABRA1 GABRA2 | 3.04e-04 | 523 | 105 | 10 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | CACNA1E TRPC6 GABRQ LRRC8D KCNJ8 KCNJ16 KCNK5 HTR3D GABRA1 GABRA2 | 4.51e-04 | 550 | 105 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | presynapse | CACNA1E NAPEPLD POLG GABBR2 NUFIP1 ITPR3 SLC8A2 SLC8A3 KCNJ8 TMED9 AFDN NLGN2 GABRA2 | 4.95e-04 | 886 | 105 | 13 | GO:0098793 |
| GeneOntologyCellularComponent | presynaptic membrane | 5.01e-04 | 277 | 105 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 8.79e-04 | 9 | 105 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | brush border | 1.02e-03 | 152 | 105 | 5 | GO:0005903 | |
| GeneOntologyCellularComponent | ankyrin-1 complex | 1.10e-03 | 10 | 105 | 2 | GO:0170014 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.33e-03 | 11 | 105 | 2 | GO:0031094 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.44e-03 | 164 | 105 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.49e-03 | 431 | 105 | 8 | GO:0031253 | |
| GeneOntologyCellularComponent | receptor complex | 2.63e-03 | 581 | 105 | 9 | GO:0043235 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 2.81e-03 | 56 | 105 | 3 | GO:0008023 | |
| GeneOntologyCellularComponent | chloride channel complex | 2.96e-03 | 57 | 105 | 3 | GO:0034707 | |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1E TRPC6 GABRQ GABBR2 LRRC8D RHCE RHD STX5 KCNJ8 KCNJ16 KCNK5 AFDN HTR3D OSMR GABRA1 GABRA2 | 3.23e-03 | 1498 | 105 | 16 | GO:0098796 |
| Domain | DUF3398 | 3.13e-06 | 6 | 102 | 3 | PF11878 | |
| Domain | DOCK_C/D_N | 3.13e-06 | 6 | 102 | 3 | IPR021816 | |
| Domain | DOCK_C | 2.53e-05 | 11 | 102 | 3 | IPR010703 | |
| Domain | DHR-1_domain | 2.53e-05 | 11 | 102 | 3 | IPR027007 | |
| Domain | DHR_2 | 2.53e-05 | 11 | 102 | 3 | PS51651 | |
| Domain | DHR_1 | 2.53e-05 | 11 | 102 | 3 | PS51650 | |
| Domain | DOCK-C2 | 2.53e-05 | 11 | 102 | 3 | PF14429 | |
| Domain | DHR-2 | 2.53e-05 | 11 | 102 | 3 | IPR027357 | |
| Domain | DHR-2 | 2.53e-05 | 11 | 102 | 3 | PF06920 | |
| Domain | DOCK | 2.53e-05 | 11 | 102 | 3 | IPR026791 | |
| Domain | InsP3_rcpt-bd | 8.83e-05 | 3 | 102 | 2 | IPR000493 | |
| Domain | Na_Ca_Ex | 8.83e-05 | 3 | 102 | 2 | IPR004836 | |
| Domain | Na_Ca_Ex_C-exten | 8.83e-05 | 3 | 102 | 2 | IPR032452 | |
| Domain | Na_Ca_ex_C | 8.83e-05 | 3 | 102 | 2 | PF16494 | |
| Domain | Neur_chan_memb | 1.15e-04 | 46 | 102 | 4 | PF02932 | |
| Domain | Neur_chan_LBD | 1.25e-04 | 47 | 102 | 4 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 1.25e-04 | 47 | 102 | 4 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 1.25e-04 | 47 | 102 | 4 | IPR006029 | |
| Domain | - | 1.25e-04 | 47 | 102 | 4 | 2.70.170.10 | |
| Domain | Neur_channel | 1.25e-04 | 47 | 102 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.25e-04 | 47 | 102 | 4 | IPR006202 | |
| Domain | UDPGT | 1.96e-04 | 21 | 102 | 3 | PF00201 | |
| Domain | UDPGT | 1.96e-04 | 21 | 102 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 1.96e-04 | 21 | 102 | 3 | IPR002213 | |
| Domain | GABAA/Glycine_rcpt | 2.59e-04 | 23 | 102 | 3 | IPR006028 | |
| Domain | PKNOX/Meis_N | 2.92e-04 | 5 | 102 | 2 | IPR032453 | |
| Domain | Ammonium_transpt | 2.92e-04 | 5 | 102 | 2 | IPR001905 | |
| Domain | Meis_PKNOX_N | 2.92e-04 | 5 | 102 | 2 | PF16493 | |
| Domain | Ammonium_transp | 2.92e-04 | 5 | 102 | 2 | PF00909 | |
| Domain | NH4_transpt_AmtB-like_dom | 2.92e-04 | 5 | 102 | 2 | IPR024041 | |
| Domain | RhesusRHD | 2.92e-04 | 5 | 102 | 2 | IPR002229 | |
| Domain | Ion_trans_dom | 4.03e-04 | 114 | 102 | 5 | IPR005821 | |
| Domain | Ion_trans | 4.03e-04 | 114 | 102 | 5 | PF00520 | |
| Domain | RIH_assoc | 4.37e-04 | 6 | 102 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 4.37e-04 | 6 | 102 | 2 | IPR013662 | |
| Domain | RIH_dom | 4.37e-04 | 6 | 102 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 4.37e-04 | 6 | 102 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 4.37e-04 | 6 | 102 | 2 | IPR015925 | |
| Domain | - | 4.37e-04 | 6 | 102 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 4.37e-04 | 6 | 102 | 2 | PF01365 | |
| Domain | GABAAa_rcpt | 4.37e-04 | 6 | 102 | 2 | IPR001390 | |
| Domain | Ins145_P3_rec | 4.37e-04 | 6 | 102 | 2 | PF08709 | |
| Domain | ARM-type_fold | 5.41e-04 | 339 | 102 | 8 | IPR016024 | |
| Domain | - | 6.09e-04 | 7 | 102 | 2 | 1.10.3430.10 | |
| Domain | Ammonium/urea_transptr | 6.09e-04 | 7 | 102 | 2 | IPR029020 | |
| Domain | ARM-like | 7.01e-04 | 270 | 102 | 7 | IPR011989 | |
| Domain | Calx_beta | 8.09e-04 | 8 | 102 | 2 | SM00237 | |
| Domain | DHC_N1 | 8.09e-04 | 8 | 102 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 8.09e-04 | 8 | 102 | 2 | IPR013594 | |
| Domain | Calx_beta | 1.04e-03 | 9 | 102 | 2 | IPR003644 | |
| Domain | NaCa_Exmemb | 1.04e-03 | 9 | 102 | 2 | IPR004837 | |
| Domain | Na_Ca_ex | 1.04e-03 | 9 | 102 | 2 | PF01699 | |
| Domain | Calx-beta | 1.04e-03 | 9 | 102 | 2 | PF03160 | |
| Domain | MIR | 1.29e-03 | 10 | 102 | 2 | PS50919 | |
| Domain | MIR | 1.29e-03 | 10 | 102 | 2 | PF02815 | |
| Domain | MIR | 1.29e-03 | 10 | 102 | 2 | SM00472 | |
| Domain | MIR_motif | 1.29e-03 | 10 | 102 | 2 | IPR016093 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.90e-03 | 45 | 102 | 3 | IPR018000 | |
| Domain | Carboxylesterase_B_CS | 2.22e-03 | 13 | 102 | 2 | IPR019819 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.57e-03 | 14 | 102 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.57e-03 | 14 | 102 | 2 | IPR024743 | |
| Domain | CARBOXYLESTERASE_B_2 | 2.57e-03 | 14 | 102 | 2 | PS00941 | |
| Domain | Dynein_heavy_dom-2 | 2.57e-03 | 14 | 102 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.57e-03 | 14 | 102 | 2 | PF08393 | |
| Domain | MT | 2.57e-03 | 14 | 102 | 2 | PF12777 | |
| Domain | AAA_8 | 2.57e-03 | 14 | 102 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 2.57e-03 | 14 | 102 | 2 | IPR011704 | |
| Domain | COesterase | 2.57e-03 | 14 | 102 | 2 | PF00135 | |
| Domain | CarbesteraseB | 2.57e-03 | 14 | 102 | 2 | IPR002018 | |
| Domain | AAA_5 | 2.57e-03 | 14 | 102 | 2 | PF07728 | |
| Domain | Helicase_C | 2.81e-03 | 107 | 102 | 4 | PF00271 | |
| Domain | HELICc | 2.81e-03 | 107 | 102 | 4 | SM00490 | |
| Domain | Helicase_C | 2.91e-03 | 108 | 102 | 4 | IPR001650 | |
| Domain | DHC_fam | 2.96e-03 | 15 | 102 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.96e-03 | 15 | 102 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.96e-03 | 15 | 102 | 2 | PF03028 | |
| Domain | HELICASE_CTER | 3.01e-03 | 109 | 102 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.01e-03 | 109 | 102 | 4 | PS51192 | |
| Domain | DEXDc | 3.01e-03 | 109 | 102 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 3.11e-03 | 110 | 102 | 4 | IPR014001 | |
| Domain | K_chnl_inward-rec_Kir_cyto | 3.37e-03 | 16 | 102 | 2 | IPR013518 | |
| Domain | IRK | 3.37e-03 | 16 | 102 | 2 | PF01007 | |
| Domain | - | 3.37e-03 | 16 | 102 | 2 | 2.60.40.1400 | |
| Domain | K_chnl_inward-rec_Kir | 3.37e-03 | 16 | 102 | 2 | IPR016449 | |
| Domain | Homeobox_KN | 3.81e-03 | 17 | 102 | 2 | PF05920 | |
| Domain | Homeobox_KN_domain | 3.81e-03 | 17 | 102 | 2 | IPR008422 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 5.78e-07 | 27 | 87 | 5 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 7.01e-07 | 28 | 87 | 5 | M924 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 7.18e-06 | 76 | 87 | 6 | MM15051 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.47e-05 | 86 | 87 | 6 | M916 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 3.33e-05 | 60 | 87 | 5 | MM15708 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 3.33e-05 | 60 | 87 | 5 | M976 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 3.75e-05 | 31 | 87 | 4 | M39369 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 6.21e-05 | 13 | 87 | 3 | MM14553 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.20e-04 | 16 | 87 | 3 | M26945 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.66e-04 | 45 | 87 | 4 | MM15694 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CACNA1E GABRQ BCHE GABBR2 KCNJ8 KCNJ16 HTR3D NLGN2 GABRA1 GABRA2 | 2.15e-04 | 411 | 87 | 10 | M735 |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.58e-04 | 270 | 87 | 8 | M15514 | |
| Pathway | WP_ESTROGEN_METABOLISM | 3.21e-04 | 22 | 87 | 3 | MM15888 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.38e-04 | 54 | 87 | 4 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.38e-04 | 54 | 87 | 4 | MM15202 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 3.63e-04 | 55 | 87 | 4 | M14933 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 3.72e-04 | 5 | 87 | 2 | M49000 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.18e-04 | 24 | 87 | 3 | MM14599 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 4.34e-04 | 103 | 87 | 5 | MM15196 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.73e-04 | 25 | 87 | 3 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 4.73e-04 | 25 | 87 | 3 | MM15820 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 4.73e-04 | 25 | 87 | 3 | MM14511 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 4.73e-04 | 25 | 87 | 3 | M605 | |
| Pathway | WP_GLUCURONIDATION | 5.33e-04 | 26 | 87 | 3 | M39404 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 5.56e-04 | 6 | 87 | 2 | M47960 | |
| Pathway | REACTOME_DRUG_ADME | 5.63e-04 | 109 | 87 | 5 | M45012 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 5.97e-04 | 27 | 87 | 3 | M12123 | |
| Pathway | KEGG_RETINOL_METABOLISM | 6.48e-04 | 64 | 87 | 4 | M9488 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 6.65e-04 | 28 | 87 | 3 | M19580 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 8.07e-04 | 178 | 87 | 6 | M2890 | |
| Pathway | PID_CDC42_REG_PATHWAY | 8.17e-04 | 30 | 87 | 3 | M83 | |
| Pathway | REACTOME_DRUG_ADME | 8.39e-04 | 119 | 87 | 5 | MM15692 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 9.10e-04 | 70 | 87 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.01e-03 | 72 | 87 | 4 | M9257 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.07e-03 | 335 | 87 | 8 | MM14503 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.25e-03 | 130 | 87 | 5 | M27454 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 1.29e-03 | 35 | 87 | 3 | M1075 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 1.32e-03 | 9 | 87 | 2 | M22034 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.32e-03 | 9 | 87 | 2 | M47852 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 1.32e-03 | 9 | 87 | 2 | MM15666 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 1.40e-03 | 36 | 87 | 3 | M1315 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 1.40e-03 | 36 | 87 | 3 | MM14544 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 1.64e-03 | 38 | 87 | 3 | M39854 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 1.64e-03 | 10 | 87 | 2 | M477 | |
| Pathway | WP_STEROID_BIOSYNTHESIS | 1.64e-03 | 10 | 87 | 2 | M39538 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.64e-03 | 10 | 87 | 2 | M47661 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 1.64e-03 | 10 | 87 | 2 | MM1401 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.67e-03 | 205 | 87 | 6 | M752 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.77e-03 | 39 | 87 | 3 | MM15695 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.93e-03 | 211 | 87 | 6 | MM14502 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.96e-03 | 144 | 87 | 5 | MM14501 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 2.00e-03 | 11 | 87 | 2 | M27336 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.00e-03 | 11 | 87 | 2 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 2.00e-03 | 11 | 87 | 2 | M27466 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.04e-03 | 41 | 87 | 3 | M7399 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 2.04e-03 | 41 | 87 | 3 | M512 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.39e-03 | 12 | 87 | 2 | M27326 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 2.39e-03 | 12 | 87 | 2 | M39611 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.50e-03 | 44 | 87 | 3 | M45014 | |
| Pathway | SIG_CHEMOTAXIS | 2.67e-03 | 45 | 87 | 3 | M5193 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 2.81e-03 | 13 | 87 | 2 | MM15078 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.81e-03 | 13 | 87 | 2 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.81e-03 | 13 | 87 | 2 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 2.81e-03 | 13 | 87 | 2 | M47751 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 2.85e-03 | 46 | 87 | 3 | M8626 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.77e-09 | 38 | 106 | 6 | 30786075 | |
| Pubmed | 7.97e-08 | 14 | 106 | 4 | 21646302 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 7.97e-08 | 14 | 106 | 4 | 14672974 | |
| Pubmed | 5.47e-07 | 6 | 106 | 3 | 32527940 | ||
| Pubmed | 5.47e-07 | 6 | 106 | 3 | 20297805 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 9.55e-07 | 7 | 106 | 3 | 8467709 | |
| Pubmed | 9.55e-07 | 7 | 106 | 3 | 8464825 | ||
| Pubmed | theta, a novel gamma-aminobutyric acid type A receptor subunit. | 9.55e-07 | 7 | 106 | 3 | 10449790 | |
| Pubmed | 9.55e-07 | 7 | 106 | 3 | 27514509 | ||
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 20610558 | ||
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 18052087 | ||
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 17179145 | ||
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 22511988 | ||
| Pubmed | 3.25e-06 | 10 | 106 | 3 | 23642732 | ||
| Pubmed | 3.25e-06 | 10 | 106 | 3 | 11465080 | ||
| Pubmed | 3.25e-06 | 10 | 106 | 3 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 3.25e-06 | 10 | 106 | 3 | 22558097 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 5.93e-06 | 12 | 106 | 3 | 20308471 | |
| Pubmed | 5.93e-06 | 12 | 106 | 3 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 5.93e-06 | 12 | 106 | 3 | 11434514 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLXNA3 POLG PIEZO1 DOCK9 ICE1 FAM83H ITPR2 ITPR3 KCNK5 AKT2 DEPDC5 NLGN2 PLEC DOCK6 | 6.87e-06 | 1105 | 106 | 14 | 35748872 |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 7.70e-06 | 13 | 106 | 3 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 7.70e-06 | 13 | 106 | 3 | 25246029 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 8188244 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23137542 | ||
| Pubmed | Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. | 9.20e-06 | 2 | 106 | 2 | 9065779 | |
| Pubmed | DCS-1, DCS-2, and DFV share amino acid substitutions at the extracellular RhD protein vestibule. | 9.20e-06 | 2 | 106 | 2 | 17900276 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 32697929 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 33931447 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 28643105 | ||
| Pubmed | Review: the molecular basis of the Rh blood group phenotypes. | 9.20e-06 | 2 | 106 | 2 | 15373666 | |
| Pubmed | Intron 4 of the RH Gene in Han Chinese, Tibetan, and Mongol Populations. | 9.20e-06 | 2 | 106 | 2 | 26579938 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 34968422 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 1898705 | ||
| Pubmed | α2-containing GABAA receptors expressed in hippocampal region CA3 control fast network oscillations. | 9.20e-06 | 2 | 106 | 2 | 23109109 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 11161244 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 35968892 | ||
| Pubmed | RH diversity in Mali: characterization of a new haplotype RHD*DIVa/RHCE*ceTI(D2). | 9.20e-06 | 2 | 106 | 2 | 25857637 | |
| Pubmed | Ca2+ regulation in the Na+/Ca2+ exchanger features a dual electrostatic switch mechanism. | 9.20e-06 | 2 | 106 | 2 | 19667209 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22738288 | ||
| Pubmed | Multiple Rh messenger RNA isoforms are produced by alternative splicing. | 9.20e-06 | 2 | 106 | 2 | 1379850 | |
| Pubmed | Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. | 9.20e-06 | 2 | 106 | 2 | 8081734 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10329015 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18973555 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23772606 | ||
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 9.20e-06 | 2 | 106 | 2 | 10497143 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 3135863 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15632133 | ||
| Pubmed | Sequences and evolution of mammalian RH gene transcripts and proteins. | 9.20e-06 | 2 | 106 | 2 | 9811965 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12393640 | ||
| Pubmed | Molecular genetic basis of the human Rhesus blood group system. | 9.20e-06 | 2 | 106 | 2 | 8220426 | |
| Pubmed | Isolation of a new cDNA clone encoding an Rh polypeptide associated with the Rh blood group system. | 9.20e-06 | 2 | 106 | 2 | 7916743 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22690701 | ||
| Pubmed | No Distinction of Orthology/Paralogy between Human and Chimpanzee Rh Blood Group Genes. | 9.20e-06 | 2 | 106 | 2 | 26872772 | |
| Pubmed | RHCE*ceTI encodes partial c and partial e and is often in cis to RHD*DIVa. | 9.20e-06 | 2 | 106 | 2 | 22804620 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 7789951 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 11724987 | ||
| Pubmed | Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve. | 9.20e-06 | 2 | 106 | 2 | 17496801 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10627438 | ||
| Pubmed | Polymorphisms in the promoter regions of RHD and RHCE genes in the Chinese Han population. | 9.20e-06 | 2 | 106 | 2 | 37823181 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 30089826 | ||
| Pubmed | Mice lacking inositol 1,4,5-trisphosphate receptors exhibit dry eye. | 9.20e-06 | 2 | 106 | 2 | 24901844 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18085262 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21073549 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 33854148 | ||
| Pubmed | Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia. | 9.20e-06 | 2 | 106 | 2 | 29193104 | |
| Pubmed | Synapse formation and clustering of neuroligin-2 in the absence of GABAA receptors. | 9.20e-06 | 2 | 106 | 2 | 18723687 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19528657 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 8063813 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 11901093 | ||
| Pubmed | RHCE variants inherited with altered RHD alleles in Brazilian blood donors. | 9.20e-06 | 2 | 106 | 2 | 27111588 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 8822955 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 8808597 | ||
| Pubmed | Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. | 9.20e-06 | 2 | 106 | 2 | 12201845 | |
| Pubmed | Variant RH alleles and Rh immunisation in patients with sickle cell disease. | 9.20e-06 | 2 | 106 | 2 | 24960646 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21056629 | ||
| Pubmed | IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. | 9.20e-06 | 2 | 106 | 2 | 16195467 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 30418133 | ||
| Pubmed | A convenient qualitative and quantitative method to investigate RHD-RHCE hybrid genes. | 9.20e-06 | 2 | 106 | 2 | 23550903 | |
| Pubmed | Molecular cloning and primary structure of the human blood group RhD polypeptide. | 9.20e-06 | 2 | 106 | 2 | 1438298 | |
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 9.20e-06 | 2 | 106 | 2 | 17603215 | |
| Pubmed | Molecular background of D(C)(e) haplotypes within the white population. | 9.20e-06 | 2 | 106 | 2 | 12084172 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15713744 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10924335 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12857961 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20233350 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 8900235 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 9647757 | ||
| Pubmed | The role of the mitochondrial NCX in the mechanism of neurodegeneration in Parkinson's disease. | 9.20e-06 | 2 | 106 | 2 | 23224884 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23742316 | ||
| Pubmed | A comprehensive survey of both RHD and RHCE allele frequencies in sub-Saharan Africa. | 9.20e-06 | 2 | 106 | 2 | 24033223 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 30699353 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 9.77e-06 | 14 | 106 | 3 | 10836148 | |
| Pubmed | 9.77e-06 | 14 | 106 | 3 | 9295054 | ||
| Pubmed | 9.77e-06 | 14 | 106 | 3 | 12432077 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 1.42e-05 | 170 | 106 | 6 | 23314748 | |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 1.50e-05 | 16 | 106 | 3 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 1.81e-05 | 17 | 106 | 3 | 20639394 | |
| Pubmed | Ecm29-mediated proteasomal distribution modulates excitatory GABA responses in the developing brain. | 2.17e-05 | 18 | 106 | 3 | 31910261 | |
| Pubmed | 2.17e-05 | 18 | 106 | 3 | 19078961 | ||
| Cytoband | 2q37 | 5.13e-05 | 31 | 106 | 3 | 2q37 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 5.08e-05 | 3 | 75 | 2 | 297 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 6.33e-05 | 19 | 75 | 3 | 563 | |
| GeneFamily | UDP glucuronosyltransferases | 3.12e-04 | 32 | 75 | 3 | 363 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 1.96e-03 | 16 | 75 | 2 | 276 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 189 | 106 | 6 | 27e5d706f10a6221f314faf642eede15deab3165 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.89e-06 | 193 | 106 | 6 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.89e-06 | 193 | 106 | 6 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-06 | 196 | 106 | 6 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.59e-05 | 156 | 106 | 5 | 0f2147abcf31a26ee5b2f4d8c5d72232612a33f0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.59e-05 | 156 | 106 | 5 | cb87f12443fdc5538b856f765fcbac9406044e10 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 166 | 106 | 5 | 5c132f505dc5f699c87913f140344fc9f8e7e0f5 | |
| ToppCell | mild-Others-CD34+_GATA2+_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.71e-05 | 172 | 106 | 5 | 379f6f271e653d5e404851e51a189bd582bb0f43 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.72e-05 | 178 | 106 | 5 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.72e-05 | 178 | 106 | 5 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.09e-05 | 180 | 106 | 5 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.09e-05 | 180 | 106 | 5 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 181 | 106 | 5 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | facs-Heart-LV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | 6dff753d65ba45db81f3cc0c9f59e1779d490955 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.47e-05 | 182 | 106 | 5 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.66e-05 | 183 | 106 | 5 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.27e-05 | 186 | 106 | 5 | a558fd00053e7dd6216b01dc8e650c30cee451f1 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.27e-05 | 186 | 106 | 5 | 75b1f342be5d6dbe0e7acd924a0ca75964f6bab0 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.27e-05 | 186 | 106 | 5 | 0c3d195077de7b4c354c127a26116438aef29244 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 8.27e-05 | 186 | 106 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 8.48e-05 | 187 | 106 | 5 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 187 | 106 | 5 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 8.70e-05 | 188 | 106 | 5 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.70e-05 | 188 | 106 | 5 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-05 | 189 | 106 | 5 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-05 | 189 | 106 | 5 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-05 | 189 | 106 | 5 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.37e-05 | 191 | 106 | 5 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-05 | 191 | 106 | 5 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-05 | 191 | 106 | 5 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.84e-05 | 193 | 106 | 5 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.84e-05 | 193 | 106 | 5 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.84e-05 | 193 | 106 | 5 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-05 | 193 | 106 | 5 | 1526f51b589a7dc7a28f35f0e788dc38d338d2bc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 194 | 106 | 5 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.03e-04 | 195 | 106 | 5 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 195 | 106 | 5 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 196 | 106 | 5 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 196 | 106 | 5 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 1.06e-04 | 196 | 106 | 5 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 196 | 106 | 5 | 22fcfb713f402ebbd43b2822f0fd919cdbfba6e4 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.06e-04 | 196 | 106 | 5 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Mast_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.11e-04 | 198 | 106 | 5 | 0af55f2b859e4626e23e2733bf9ae2ace4547079 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Mast_cell-Mast_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.11e-04 | 198 | 106 | 5 | f75800b4f3cf0d493226db8db7c949caade0ff90 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-04 | 198 | 106 | 5 | 122215d9288533ad03562cf777e846504863df9a | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-Mast_cells|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.11e-04 | 198 | 106 | 5 | 45089e0adf2c00f4b0bccd701f4daebf25858006 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-04 | 198 | 106 | 5 | 307dd09e6bc820a148f3000f18dae7aedba4be0b | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Mast_cell-Mast_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.11e-04 | 198 | 106 | 5 | 4163220f4ccb825a8399298cfac8411eb2acc9a2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.14e-04 | 199 | 106 | 5 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| Drug | Finrazole | 3.32e-09 | 51 | 104 | 7 | CID000178036 | |
| Drug | prazepam | 3.46e-08 | 21 | 104 | 5 | CID000004890 | |
| Drug | P4-s | 8.92e-08 | 25 | 104 | 5 | CID000004838 | |
| Drug | hexobarbital | 1.23e-07 | 127 | 104 | 8 | CID000003608 | |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.06e-07 | 188 | 104 | 9 | 5019_UP | |
| Drug | alpha IMGBL | 2.85e-07 | 13 | 104 | 4 | CID000131516 | |
| Drug | 3-aminopropylphosphinic acid | 3.29e-07 | 32 | 104 | 5 | CID006335948 | |
| Drug | hydratropic acid | 3.69e-07 | 4 | 104 | 3 | ctd:C013025 | |
| Drug | 2-vanillin | 3.69e-07 | 4 | 104 | 3 | ctd:C060843 | |
| Drug | diphenylacetic acid | 3.69e-07 | 4 | 104 | 3 | ctd:C037760 | |
| Drug | pinazepam | 5.39e-07 | 15 | 104 | 4 | CID000040391 | |
| Drug | naringenin chalcone | 9.20e-07 | 5 | 104 | 3 | ctd:C027329 | |
| Drug | isovaleric acid | 9.20e-07 | 5 | 104 | 3 | ctd:C008216 | |
| Drug | anthrarobin | 9.20e-07 | 5 | 104 | 3 | ctd:C032186 | |
| Drug | biphenylylacetic acid | 9.20e-07 | 5 | 104 | 3 | ctd:C012776 | |
| Drug | gabapentin | 1.10e-06 | 169 | 104 | 8 | CID000003446 | |
| Drug | clorazepate | 1.20e-06 | 18 | 104 | 4 | CID000002809 | |
| Drug | phenazepam | 1.20e-06 | 18 | 104 | 4 | CID000040113 | |
| Drug | ZK 93426 | 1.51e-06 | 19 | 104 | 4 | CID000115210 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 1.83e-06 | 6 | 104 | 3 | ctd:C543211 | |
| Drug | alloin | 1.83e-06 | 6 | 104 | 3 | ctd:C006457 | |
| Drug | 3-phenylpropionic acid | 1.83e-06 | 6 | 104 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 1.83e-06 | 6 | 104 | 3 | ctd:D007216 | |
| Drug | 2',5'-dihydroxychalcone | 1.83e-06 | 6 | 104 | 3 | ctd:C107497 | |
| Drug | halazepam | 1.88e-06 | 20 | 104 | 4 | CID000031640 | |
| Drug | EBOB | 1.88e-06 | 20 | 104 | 4 | CID000115223 | |
| Drug | bicuculline methochloride | 2.32e-06 | 21 | 104 | 4 | CID000123659 | |
| Drug | R 5135 | 2.32e-06 | 21 | 104 | 4 | CID000119544 | |
| Drug | nitrazepam | 2.38e-06 | 47 | 104 | 5 | CID000004506 | |
| Drug | propofol | 2.74e-06 | 191 | 104 | 8 | CID000004943 | |
| Drug | imidazenil | 2.82e-06 | 22 | 104 | 4 | CID000119194 | |
| Drug | thiamylal | 2.93e-06 | 49 | 104 | 5 | CID003032285 | |
| Drug | 2',4'-dihydroxychalcone | 3.20e-06 | 7 | 104 | 3 | ctd:C059354 | |
| Drug | zolazepam | 3.40e-06 | 23 | 104 | 4 | CID000035775 | |
| Drug | Suprofen [40828-46-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 3.45e-06 | 197 | 104 | 8 | 3005_DN | |
| Drug | gamma-acetylenic GABA | 4.07e-06 | 24 | 104 | 4 | CID000003452 | |
| Drug | cinnamic acid | 4.07e-06 | 24 | 104 | 4 | ctd:C029010 | |
| Drug | medazepam | 4.07e-06 | 24 | 104 | 4 | CID000004041 | |
| Drug | SL 75102 | 4.07e-06 | 24 | 104 | 4 | CID005751746 | |
| Drug | isonipecotic acid | 4.83e-06 | 25 | 104 | 4 | CID000003773 | |
| Drug | 5,6-benzoquinoline | 4.83e-06 | 25 | 104 | 4 | CID000006796 | |
| Drug | beta-CCE | 4.83e-06 | 25 | 104 | 4 | CID000105078 | |
| Drug | 1,4-dihydroxyanthraquinone | 5.10e-06 | 8 | 104 | 3 | ctd:C034890 | |
| Drug | SKF97541 | 5.68e-06 | 26 | 104 | 4 | CID000005230 | |
| Drug | V-X-A | 5.68e-06 | 26 | 104 | 4 | CID006369389 | |
| Drug | Thymol | 5.68e-06 | 26 | 104 | 4 | ctd:D013943 | |
| Drug | pitrazepin | 6.65e-06 | 27 | 104 | 4 | CID000146222 | |
| Drug | lindane | 6.93e-06 | 154 | 104 | 7 | CID000000727 | |
| Drug | AC1MRQNQ | 7.62e-06 | 9 | 104 | 3 | CID003522271 | |
| Drug | DHPASiU | 7.62e-06 | 9 | 104 | 3 | CID000197602 | |
| Drug | 3-iodophenol | 7.62e-06 | 9 | 104 | 3 | CID000012272 | |
| Drug | AC1L4J7U | 7.62e-06 | 9 | 104 | 3 | CID000186631 | |
| Drug | Chebi:32663 | 7.62e-06 | 9 | 104 | 3 | CID005460873 | |
| Drug | CARMINE | 7.73e-06 | 28 | 104 | 4 | CID000014749 | |
| Drug | chlormethiazole | 7.73e-06 | 28 | 104 | 4 | CID000010783 | |
| Drug | mephobarbital | 7.73e-06 | 28 | 104 | 4 | CID000008271 | |
| Drug | 5 beta-pregnanediol | 8.07e-06 | 60 | 104 | 5 | CID000012547 | |
| Drug | 3-OH | 8.76e-06 | 61 | 104 | 5 | CID000068152 | |
| Drug | etazolate | 8.94e-06 | 29 | 104 | 4 | CID000003277 | |
| Drug | CGP 35348 | 9.50e-06 | 62 | 104 | 5 | CID000107699 | |
| Drug | valproate | CACNA1E UGT1A10 UGT1A8 UGT1A7 POLG GABRQ GABBR2 ITPR3 GABRA1 GABRA2 | 9.88e-06 | 381 | 104 | 10 | CID000003121 |
| Drug | guvacine | 1.03e-05 | 30 | 104 | 4 | CID000003532 | |
| Drug | allylglycine | 1.03e-05 | 30 | 104 | 4 | CID000014044 | |
| Drug | Glucuronides | 1.09e-05 | 10 | 104 | 3 | ctd:D020719 | |
| Drug | 2,6-dihydroxyanthraquinone | 1.09e-05 | 10 | 104 | 3 | ctd:C034889 | |
| Drug | AC1L1J7N | 1.11e-05 | 64 | 104 | 5 | CID000004902 | |
| Drug | nordiazepam | 1.11e-05 | 64 | 104 | 5 | CID000002997 | |
| Drug | SKF89976A | 1.18e-05 | 31 | 104 | 4 | CID000092409 | |
| Drug | NNAL | 1.34e-05 | 32 | 104 | 4 | CID000104856 | |
| Drug | homotaurine | 1.34e-05 | 32 | 104 | 4 | CID000001646 | |
| Drug | 3 -hydroxypregn-5-en-20-one | 1.38e-05 | 238 | 104 | 8 | CID000001027 | |
| Drug | fosazepam | 1.49e-05 | 11 | 104 | 3 | CID000037114 | |
| Drug | C19H18ClN3O | 1.49e-05 | 11 | 104 | 3 | CID000027452 | |
| Drug | flutoprazepam | 1.49e-05 | 11 | 104 | 3 | CID000003400 | |
| Drug | Arfendazam | 1.49e-05 | 11 | 104 | 3 | CID000065803 | |
| Drug | camazepam | 1.49e-05 | 11 | 104 | 3 | CID000037367 | |
| Drug | Bu-1014 | 1.49e-05 | 11 | 104 | 3 | CID015942721 | |
| Drug | Vanillic Acid | 1.49e-05 | 11 | 104 | 3 | ctd:D014641 | |
| Drug | Zapizolam | 1.49e-05 | 11 | 104 | 3 | CID000068832 | |
| Drug | Reclazepam | 1.49e-05 | 11 | 104 | 3 | CID003052777 | |
| Drug | iclazepam | 1.49e-05 | 11 | 104 | 3 | CID000068777 | |
| Drug | menitrazepam | 1.49e-05 | 11 | 104 | 3 | CID000189875 | |
| Drug | 4-nitrophenyl)imidazole | 1.49e-05 | 11 | 104 | 3 | CID000123155 | |
| Drug | Serin hydrazid | 1.49e-05 | 11 | 104 | 3 | CID000041637 | |
| Drug | AC1O5XMV | 1.49e-05 | 11 | 104 | 3 | CID006442661 | |
| Drug | sulazepam | 1.49e-05 | 11 | 104 | 3 | CID000017931 | |
| Drug | elfazepam | 1.49e-05 | 11 | 104 | 3 | CID000065445 | |
| Drug | triflubazam | 1.49e-05 | 11 | 104 | 3 | CID000031157 | |
| Drug | uldazepam | 1.49e-05 | 11 | 104 | 3 | CID000034274 | |
| Drug | gidazepam | 1.49e-05 | 11 | 104 | 3 | CID000121919 | |
| Drug | fletazepam | 1.49e-05 | 11 | 104 | 3 | CID000036834 | |
| Drug | CGS 8216 | 1.52e-05 | 33 | 104 | 4 | CID000104916 | |
| Drug | AC1L2FYN | 1.52e-05 | 33 | 104 | 4 | CID000071333 | |
| Drug | riluzole | 1.54e-05 | 174 | 104 | 7 | CID000005070 | |
| Drug | lamotrigine | 1.55e-05 | 116 | 104 | 6 | CID000003878 | |
| Drug | amobarbital | 1.71e-05 | 34 | 104 | 4 | CID000002163 | |
| Drug | temazepam | 1.71e-05 | 34 | 104 | 4 | CID000005391 | |
| Drug | estazolam | 1.93e-05 | 35 | 104 | 4 | CID000003261 | |
| Drug | flurazepam | 1.93e-05 | 35 | 104 | 4 | CID000003393 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 1.93e-05 | 35 | 104 | 4 | CID010436171 | |
| Disease | insomnia, bilirubin measurement | 4.53e-08 | 11 | 103 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 4.11e-07 | 5 | 103 | 3 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 4.11e-07 | 5 | 103 | 3 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 4.11e-07 | 5 | 103 | 3 | EFO_0801853 | |
| Disease | X-21339 measurement | 1.43e-06 | 7 | 103 | 3 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0800766 | |
| Disease | X-11442 measurement | 3.42e-06 | 9 | 103 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 3.42e-06 | 9 | 103 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 3.42e-06 | 9 | 103 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 3.42e-06 | 9 | 103 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 3.42e-06 | 9 | 103 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 3.42e-06 | 9 | 103 | 3 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 3.42e-06 | 9 | 103 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 3.42e-06 | 9 | 103 | 3 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 3.42e-06 | 9 | 103 | 3 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 4.87e-06 | 10 | 103 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 4.87e-06 | 10 | 103 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 4.87e-06 | 10 | 103 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 4.87e-06 | 10 | 103 | 3 | EFO_0800867 | |
| Disease | pregnenetriol sulfate measurement | 6.68e-06 | 11 | 103 | 3 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 6.68e-06 | 11 | 103 | 3 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 6.68e-06 | 11 | 103 | 3 | EFO_0800972 | |
| Disease | X-21796 measurement | 6.68e-06 | 11 | 103 | 3 | EFO_0800825 | |
| Disease | aldosterone measurement | 6.68e-06 | 11 | 103 | 3 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 8.88e-06 | 12 | 103 | 3 | EFO_0800079 | |
| Disease | biliverdin measurement | 8.88e-06 | 12 | 103 | 3 | EFO_0021033 | |
| Disease | pregnenetriol disulfate measurement | 1.15e-05 | 13 | 103 | 3 | EFO_0800587 | |
| Disease | retinol dehydrogenase 16 measurement | 1.15e-05 | 13 | 103 | 3 | EFO_0802007 | |
| Disease | Anemia, Hemolytic, Congenital | 1.21e-05 | 2 | 103 | 2 | C0002881 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.71e-05 | 17 | 103 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | X-21441 measurement | 2.71e-05 | 17 | 103 | 3 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 3.24e-05 | 18 | 103 | 3 | EFO_0801382 | |
| Disease | Rh Deficiency Syndrome | 3.61e-05 | 3 | 103 | 2 | C0272052 | |
| Disease | indole-3-carboxylate measurement | 3.61e-05 | 3 | 103 | 2 | EFO_0800043 | |
| Disease | Rh-Null, Regulator Type | 3.61e-05 | 3 | 103 | 2 | C1849387 | |
| Disease | blood 4-oxo-retinoic acid measurement | 3.61e-05 | 3 | 103 | 2 | EFO_0022216 | |
| Disease | tissue factor measurement | 5.25e-05 | 21 | 103 | 3 | EFO_0010623 | |
| Disease | temporal horn of lateral ventricle volume measurement | 1.20e-04 | 72 | 103 | 4 | EFO_0010333 | |
| Disease | neuroblastoma, cutaneous melanoma | 1.27e-04 | 28 | 103 | 3 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 1.41e-04 | 29 | 103 | 3 | EFO_0010551 | |
| Disease | response to dolutegravir | 1.57e-04 | 30 | 103 | 3 | EFO_0600017 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 1.79e-04 | 6 | 103 | 2 | EFO_0800566 | |
| Disease | thyroxine measurement | 2.08e-04 | 83 | 103 | 4 | EFO_0005130 | |
| Disease | vitamin D deficiency | 2.94e-04 | 37 | 103 | 3 | EFO_0003762 | |
| Disease | restless legs syndrome (implicated_via_orthology) | 3.33e-04 | 8 | 103 | 2 | DOID:0050425 (implicated_via_orthology) | |
| Disease | status epilepticus (biomarker_via_orthology) | 4.25e-04 | 100 | 103 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | epilepsy (is_implicated_in) | 4.28e-04 | 9 | 103 | 2 | DOID:1826 (is_implicated_in) | |
| Disease | apolipoprotein B measurement | 5.32e-04 | 663 | 103 | 9 | EFO_0004615 | |
| Disease | indoleacetate measurement | 5.33e-04 | 10 | 103 | 2 | EFO_0021015 | |
| Disease | adseverin measurement | 5.33e-04 | 10 | 103 | 2 | EFO_0801358 | |
| Disease | vitamin D measurement, COVID-19 | 6.77e-04 | 49 | 103 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 7.78e-04 | 12 | 103 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | dodecanedioate measurement | 7.78e-04 | 12 | 103 | 2 | EFO_0021054 | |
| Disease | X-24588 measurement | 9.18e-04 | 13 | 103 | 2 | EFO_0800898 | |
| Disease | bilirubin measurement | 9.30e-04 | 442 | 103 | 7 | EFO_0004570 | |
| Disease | urate measurement, spine bone mineral density | 1.11e-03 | 58 | 103 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | Malignant neoplasm of breast | DYNC2H1 CYP17A1 BCHE COLGALT2 PKDREJ MEIS1 RHD SLC8A3 TAS2R13 STX5 AKT2 | 1.33e-03 | 1074 | 103 | 11 | C0006142 |
| Disease | food allergy measurement, parental genotype effect measurement | 1.78e-03 | 18 | 103 | 2 | EFO_0005939, EFO_0007016 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.78e-03 | 147 | 103 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | platelet crit | ATRX NUP210L PIEZO1 TRPC6 DOCK10 RHCE RHD ITPR2 PLEC MFSD13A | 1.84e-03 | 952 | 103 | 10 | EFO_0007985 |
| Disease | response to mitochondrial complex I inhibitor | 1.99e-03 | 19 | 103 | 2 | EFO_0600033 | |
| Disease | leukemia (implicated_via_orthology) | 1.99e-03 | 19 | 103 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | malignant astrocytoma (is_marker_for) | 2.91e-03 | 23 | 103 | 2 | DOID:3069 (is_marker_for) | |
| Disease | functional brain measurement | 3.00e-03 | 82 | 103 | 3 | EFO_0007849 | |
| Disease | longitudinal BMI measurement | 3.00e-03 | 82 | 103 | 3 | EFO_0005937 | |
| Disease | hormone measurement | 3.21e-03 | 84 | 103 | 3 | EFO_0004730 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FLKWGSQAFHNMRII | 156 | P21399 | |
| KEVMEHRFFLSINWQ | 401 | P31751 | |
| FHFINMWLFNRLVTD | 791 | P55196 | |
| MHSKVTIICIRFLFW | 1 | P06276 | |
| RWHFIMLNDTKRNTI | 151 | Q6P2P2 | |
| HMVKSQVFYWIVLSL | 471 | Q15878 | |
| FTFSEFHLLKTMLLW | 266 | Q32M84 | |
| SFDHKWMVIQTLTRI | 541 | Q9Y6D6 | |
| SMQTHAARFKTFFNW | 251 | Q13489 | |
| HMAAFFAASDWLVRN | 401 | O94923 | |
| RSTNLFMKLDSVFIW | 6 | P48448 | |
| LAHFWTTKAFLPAMT | 146 | Q8NBQ5 | |
| KMQRTVNTIWFLHLT | 51 | Q16581 | |
| FWMTLQDFKTHFVLL | 316 | A8MX76 | |
| HETSARLLFMAVKWA | 221 | Q9Y5X4 | |
| MTWKVHSIRNNFTYL | 351 | Q99650 | |
| HIWKLFENFLVDMAR | 1446 | Q14571 | |
| NTSWKINLFMQFRDH | 216 | Q14573 | |
| KVATNIMRAWLFQHL | 281 | O00470 | |
| KVLAILWFHSMDISF | 66 | P0C646 | |
| LDNTFLMTKLHFWRF | 436 | P0C881 | |
| LDNTFLMTKLHFWRF | 436 | B2RC85 | |
| NAAFEIKLHWMAVTA | 1381 | O75140 | |
| IKLHWMAVTAAVLFE | 1386 | O75140 | |
| KWSNSFHHFVKMALT | 241 | Q8IVH8 | |
| DLKWRHTLVIFTMSF | 66 | Q15842 | |
| TWISRHKEMTFIFTD | 136 | Q8NES3 | |
| IVSMEIFFKAWLHNS | 216 | Q8TC57 | |
| AFVTSQRALIWKGHM | 561 | Q6ZRQ5 | |
| ALWRHFFSFLKSQRM | 716 | Q6ZRQ5 | |
| ITMFFHQTWKDSRLA | 106 | Q9UN88 | |
| LMASKIWTPDTFFHN | 116 | P47869 | |
| IVSTVQNFLFWHMKD | 381 | Q8IWD5 | |
| VAEKMLTNWFTFLLH | 1411 | P51805 | |
| FVNWKVSMFVEVHKA | 241 | O95279 | |
| HSRWTKALMEEFFRQ | 381 | Q01064 | |
| ALEINKMISFWRNAH | 791 | P54098 | |
| KMISFWRNAHKRISS | 796 | P54098 | |
| MELSWHVVFIALLSF | 1 | P09848 | |
| KVATNIMRAWLFQHL | 271 | Q99687 | |
| SQSSMIKHVAWLIFT | 741 | Q9BXB1 | |
| LMASKIWTPDTFFHN | 116 | P14867 | |
| GFVTAQSFIAMWRKL | 776 | Q06190 | |
| TIVMFWKAFHKLTLE | 936 | Q9UII4 | |
| NMKSRLEFTKEVFHW | 2201 | Q8NCM8 | |
| KLFQDFQMLSRIWTH | 1871 | P46100 | |
| EKLTLFIANMWHDIF | 2026 | Q9Y2F5 | |
| WHDIFLSQSVINKAM | 2036 | Q9Y2F5 | |
| WMQVASLNEKRTFFH | 421 | Q9P2N7 | |
| EMRAHVNSSWFIFQK | 366 | O15229 | |
| HFWKVSTQGLFVAMF | 396 | Q9NZS9 | |
| FVNRFQKWFQSMVHI | 241 | Q6E213 | |
| MKIQLFFFILHFWVT | 1 | Q30KQ9 | |
| IRWMHSFNFVLSANL | 201 | P15169 | |
| FAAWMAQRLKTHLLT | 251 | Q8WZ79 | |
| WFFFAIILKSMAQHL | 991 | Q96BY6 | |
| AILQHAWFFFQLMVK | 926 | Q96HP0 | |
| WFFFDVLIKSMAQHL | 961 | Q9BZ29 | |
| WQLHRRLAMATFALF | 121 | P05093 | |
| AMIFCHTRKTASWLA | 336 | Q9UMR2 | |
| MFAKTWRVHAIFKNV | 571 | O75899 | |
| QFVSVGVKHMKFWTL | 1521 | Q6ZMW3 | |
| MFADRWLFSTNHKDI | 1 | P00395 | |
| MIFCHTRKTASWLAA | 336 | Q9NUU7 | |
| SFMWSFEKIHRSLAH | 246 | Q6ZRV2 | |
| WPTSRFAHVMKLRQA | 136 | Q8IYK4 | |
| AFSVPVMTHRWNRFA | 151 | P39059 | |
| KHGMTLRNWASFFVV | 151 | P0C7U9 | |
| ARHRNFLWFVSMDLV | 261 | Q14CX5 | |
| KEHRRVFQAMWLSFL | 246 | Q9BVI4 | |
| MRRKTLLALFTDHQW | 446 | Q8NFZ4 | |
| FRLWMTTEAHKQFPI | 4126 | Q8TE73 | |
| IHTIILMVSSNFWFK | 171 | Q7L1W4 | |
| HRRKFDNFSSLMLEW | 806 | Q5VU65 | |
| EFRQTWKLFSSHMNI | 676 | O14830 | |
| SVTWIAFFLQMRAKE | 1101 | A6NES4 | |
| GLRIMIFSWIVSNHF | 81 | Q9NYV9 | |
| SRQVKHVMNFTNWAI | 406 | Q9UPN9 | |
| LKIAAMRKDFFSHAW | 661 | Q4G0N8 | |
| MRKDFFSHAWNIFEL | 666 | Q4G0N8 | |
| LRKNHMWFSIFASVV | 1366 | Q9NTG1 | |
| FMEIKSHVFFSLINW | 346 | O00141 | |
| MRVHNSTFLWFIPFV | 401 | Q7Z333 | |
| QTVMSKNLFWFRHRP | 461 | Q9NSC7 | |
| HMVLVTKVSRYSLWF | 381 | P22891 | |
| VAAIFFVVWDHLMAK | 136 | Q9HAS3 | |
| KFHSQLARALWTNML | 1006 | Q6P1J6 | |
| VKNTFLRMWIYSHHI | 151 | Q9UIY3 | |
| FQSVTSNRWLMVKIF | 326 | Q13190 | |
| LWVQFSHAMDALLFR | 421 | Q70Z44 | |
| ANVRFVAHWNIAKSM | 326 | O94762 | |
| AIGVWQMRHLKSFFE | 216 | Q9BVK6 | |
| DSIIWAFKHTMRNVA | 876 | O14980 | |
| MRTFKSSFSIWRHQV | 781 | Q9ULJ3 | |
| SHWFTMQSVVEKLIL | 36 | Q9HAW8 | |
| RHSWSSVAFNLFMLA | 71 | Q02161 | |
| RHSWSSVAFNLFMLA | 71 | P18577 | |
| FTAHEKIVQFHWRNM | 206 | Q9UHK0 | |
| NWLFLKSVPHFSMAA | 46 | Q9NR96 | |
| NWFKRRASKFMTHVA | 116 | Q9NWX6 | |
| MTFKQRWVRANHAAI | 301 | Q8IV42 | |
| IFTTLVDTKWRHMFV | 61 | Q9NPI9 | |
| VDTKWRHMFVIFSLS | 66 | Q9NPI9 | |
| HSFVAAATKELMWLN | 756 | Q15149 | |
| SKRFWMTAIVFTEIA | 1726 | Q92508 | |
| FIARFMAFWHASKAQ | 541 | Q9Y210 | |
| SHWFTMQSVVEKLIL | 36 | Q9HAW7 | |
| FVSVLHALMAALAQW | 756 | O43156 | |
| SHWFTMQSVVEKLIL | 36 | Q9HAW9 | |
| ESLARLVAMVFQWFH | 521 | Q9P2D8 | |
| MHFLTVFWKVLFACV | 726 | Q9UPR5 | |
| VMHFLTVFWKVLFAC | 731 | P57103 | |
| FVFTPSQHWCKRTLM | 246 | Q6IQ20 |